ATRA - Atara Biotherapeutics Inc
IEX Last Trade
7.56
0.500 6.614%
Share volume: 78,556
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.06
0.50
7.08%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-02-08 | 2023-05-08 | 2023-08-08 | 2023-11-01 | 2024-03-28 | 2024-05-09 | |
| Total revenue | 51.579 M | 4.459 M | 221.000 K | 1.226 M | 957.000 K | 2.138 M | 4.252 M | 27.357 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 216.000 K | 2.895 M | 2.615 M | 3.160 M | 1.985 M | |
| Gross profit | 51.579 M | 4.459 M | 221.000 K | 1.010 M | -1.938 M | -477.000 K | 1.092 M | 25.372 M | |
| -91.36% | -95.04% | 357.01% | -291.88% | 75.39% | 328.93% | 2,223.44% | |||
| Operating expenses | 83.711 M | 89.081 M | 75.760 M | 76.028 M | 69.476 M | 69.135 M | 61.054 M | 56.619 M | |
| Selling general and admin | 18.813 M | 18.924 M | 13.245 M | 13.872 M | 13.335 M | 12.247 M | 11.454 M | 11.113 M | |
| Research and development | 64.898 M | 70.157 M | 62.515 M | 62.156 M | 56.141 M | 56.888 M | 49.600 M | 45.506 M | |
| Total expenses | 83.711 M | 89.081 M | 75.760 M | 76.244 M | 72.371 M | 71.750 M | 64.214 M | 58.604 M | |
| 6.41% | -14.95% | 0.64% | -5.08% | -0.86% | -10.50% | -8.74% | |||
| Operating income | -32.132 M | -84.622 M | -75.539 M | -75.018 M | -71.414 M | -69.612 M | -59.962 M | -31.247 M | |
| Ebit | -32.132 M | -84.622 M | -75.539 M | -75.018 M | -71.414 M | -69.612 M | -59.962 M | -31.247 M | |
| Pretax income | 18.466 M | -84.081 M | -74.570 M | -74.749 M | -71.107 M | -69.816 M | -60.439 M | -31.728 M | |
| -555.33% | -11.31% | 0.24% | -4.87% | -1.82% | -13.43% | -47.50% | |||
| Income tax | 0.000 | 10.000 K | 2.000 K | 22.000 K | 1.000 K | -19.000 K | 11.000 K | 24.000 K | |
| Net income basic | 18.466 M | -84.091 M | -74.572 M | -74.771 M | -71.108 M | -69.797 M | -60.450 M | -31.752 M | |
| -555.38% | 11.32% | -0.27% | 4.90% | 1.84% | 13.39% | 47.47% | |||
| Net income | 18.466 M | -84.091 M | -74.572 M | -74.771 M | -71.108 M | -69.797 M | -60.450 M | -31.752 M | |
| -555.38% | 11.32% | -0.27% | 4.90% | 1.84% | 13.39% | 47.47% |